Proglumetacin
![]()  | |
| Clinical data | |
|---|---|
| Other names | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate | 
| AHFS/Drugs.com | International Drug Names | 
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Hepatic. Undergoes enterohepatic recirculation | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C46H58ClN5O8 | 
| Molar mass | 844.45 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
| (verify) | |
Proglumetacin (usually as the maleate salt, trade names Afloxan, Protaxon and Proxil) is a nonsteroidal anti-inflammatory drug (NSAID). It is metabolized in the body to indometacin and proglumide,[1] a drug with antisecretory effects that helps prevent injury to the stomach lining.
References
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
